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Abstract 
Fungi of the Candida genus have caused an increasing number of infections over the past 
30 years, with Candida albicans being the most common species.  Candida parapsilosis, 
however, is an emerging threat as the second most prevalent species. This study focused on 
characterizing virulence in 14 C. parapsilosis clinical isolates using a variety of in vitro and in 
vivo assays.  The results reveal a correlation between relatively low levels of adhesion to acrylic 
surfaces, smooth colony morphology, and virulence.  
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Introduction 
While scientists have been working for the better part of a century to develop agents that seek 
out and destroy bacterial pathogens, most fungal infections are still difficult or impossible to 
treat clinically.  A detailed survey showed that an average American hospital in the 1980s 
contained at least 15 different isolates of fungal pathogens in treatment centers.  These same 
organisms were responsible for about 40% of all mortalities caused by nosocomial infections in 
that same time period (Jarvis 1995).  Fungi, like their human hosts, are eukaryotic and 
challenging to treat.  The fundamental similarities of their cellular mechanisms make it difficult 
to develop drugs that selectively target the fungal pathogen, while leaving the host unaffected. 
These fungal infections are becoming an increasing public health concern as instances of 
infection are still relatively high in both countries with advanced medical technology and 
underdeveloped countries. Hospital patients and immunocompormised individuals are more 
susceptible to fungal infections of the bloodstream, which can turn fatal if not treated promptly.  
While medical science recognizes the presence of these diseases, the development of new 
treatments is rather slow, hence the relatively limited number of antifungal agents.  Thus there is 
an unmet need for more avenues for antifungal therapy.    
Candida spp are some of the most common causes of mycosis; particularly the species Candida 
albicans.  Although this organism exists naturally on human skin and inside the GI tract, it can 
occasionally cause deep tissue or blood stream infections.  As of 2010 an estimated 63,000 cases 
of Candida-based infections occurred in the United States with mortality rates up to 25% (Evans 
2010).   C. albicans is by far the most prevalent of these pathogens, causing nearly 66% of all 
Candida infections as of 2008 (Trofa, Gacser and Nosanchuk 2008).  While C. albicans remains 
the predominant species, Candida parapsilosis has also been responsible for significant number 
of mortalities and has been increasing in prevalence over the past few years.  This study 
characterizes the virulence of 14 clinical isolates of C. parapsilosis using a series of in vivo and 
in vitro assays.   
Recent clinical studies in portions of Europe and Asia indicate that the presence of C. 
parapsilosis in blood samples is outnumbering the cases of C. albicans (Trofa, Gacser and 
Nosanchuk 2008).  This pathogen is responsible for causing fungemia, especially in 
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immunocompromised patients, as a result of injury or preexisting conditions (Laffey and Butler 
2005).  The yeast can also cause endocarditis, peritonitis, ocular infections, and other ailments 
that all stem from the yeast successfully entering the blood stream (Trofa, Gacser and Nosanchuk 
2008).  One of the most significant facts about C. parapsilosis is that it is not limited to growth 
in the human body like C. albicans and C. tropicalis.  With the ability to harbor itself in a variety 
of other living hosts and environments (see Table 1 for reference), it is important to profile the 
virulence of various isolates of this organism in case the increasing trend of infection does not 
cease.   
Phylogenetic Analysis of C. parapsilosis 
C. parapsilosis has been classified and reclassified since the mid-1990s as the number of groups 
researching the pathogenic yeast has increased.  The fungal species was originally classified in 
1995 based on isoenzyme profiles and comparisons of specific DNA fragment sequences (Lin, et 
al. 1995). Group I is significantly larger than the other two groups classified in Lin et al.’s study, 
and contains all of the isolates used in the research detailed in this report (see Table 1).  Nearly 
one decade later, Tavanti et al. reclassified the C. parapsilosis phylogeny into three separate 
species that closely resembled the groups used by Lin et al.  These separate species were defined 
by analysis of 4 specific genes (COX3, L1A1, SADH, SYA1).  The new species are illustrated 
below in Figure 1 (Tavanti, et al. 2005).   
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Figure 1: Candida phylogeny post-2005 classification (Tavanti, et al. 2005).  C. parapsilosis, formerly three groups, is now 
classified as C. parapsilosis, C. orthopsilosis, and C. metapsilosis.   
The three new species (C. parapsilosis, C. orthopsilosis, and C. metapsilosis) are outlined in the blue box 
with the former C. parapsilosis classifications in parentheses (Lin, et al. 1995).  The 14 clinical isolates 
(Table 1) used in the experiments detailed in this report are officially classified as Candida parapsilosis 
(formerly Group 1) that were obtained from Geraldine Butler’s laboratory.   
Table 1: C. parapsilosis Isolates used in this study were obtained from Geraldine Butler and were originally sourced by 
Tavanti, et al. 2005.   
Strain I.D. Geographic Origin Isolate Location 
J931058 Belgium  Nail 
103 London, UK  Anus 
73/107  London, UK  Mouth 
81/040  London, UK  Toe 
J93063/1 Africa  Cat Hair 
90-137 San Jose, USA  Orbital Tissue 
74/046  Leeds, UK  Aortic Valve 
J961250 Lisbon, Portugal  Nail 
J931845 Japan Unknown 
J950218  USA  Unknown 
81/041 Mayo Clinic, USA  Vagina 
73/037 Leeds, UK Vagina 
CLIB214 Puerto Rico   Feces  
CDC317 Clinical Isolate Clinical Isolate 
 
(Group 1) 
(Group 2) 
(Group 3) 
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The variety of tissues these isolates were obtained from shows that this species is capable of living and 
causing infection in a variety of tissue types, ranging from cat hair to heart valves.  Furthermore, the 
CDC317 isolate has been known to cause outbreaks of infection, and was received considerable attention 
as results were obtained (Kuhn, et al. 2004).  We used a variety of in vitro and in vivo assays to 
characterize the virulence of these clinical isolates.  We used a Candida albicans strain (SN250) 
as a control in many experiments, as it is known to be virulent and elicit a positive pathogenic 
response. 
In vivo Virulence Assays  
In this study we characterized isolates of C. parapsilosis by infecting the model host 
Caenorhabditis elegans. Nematodes have been used extensively to study virulence and immunity 
as they have been well studied, including a fully sequenced genome (Chiasson, et al. 2010).  C. 
elegans evoke a similar immune response to pathogens that is genetically conserved in a wide 
variety of species including humans.  Furthermore, their transparent body type allows 
visualization of metabolic activity in vivo¸ as well as a short life cycle, and relative ease of 
culturing and sustaining strains (Jain, Yun, et al. 2009).  In addition, many microbial pathogens 
(including fungi) contain genetic elements that are required for pathogenicity in both mammals 
and C. elegans¸ leading to the conclusion that relative virulence levels among different C. 
parapsilosis isolates observed in nematode infections should be comparable to those seen in 
humans and other warm-blooded organisms (Sofro, Begun and Ausubel 2005).  
We used a quantitative survival assay for measuring virulence of particular C. parapsilosis 
isolates by determining the life span of infected worms relative to other strains of the fungi as 
well as Candida albicans strains with established levels of very high virulence.  This simple test 
produces results that are clear to interpret.  It is considerably more difficult, however, to measure 
how significant an effect a disease-inducing agent has on a host before either organism dies.  A 
specialized assay was required in this experiment to observe the virulence of the various isolates 
of C. parapsilosis apart from the lethality of the strains.   
We used a qualitative marker for infection called the Deformed Anal Region (Dar) assay to 
measure relative virulence among isolates.  Infected C. elegans show a swollen post-anal tail 
region phenotype when infected by fungal pathogens such as S. cerevisiae and C. parapsilosis 
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(Jain, Yun, et al. 2009).  This phenotype is visible under a light dissection microscope and does 
not require any type of probe, dye, or labeling procedure to observe.  Another major benefit of 
this assay is the speed and convenience of the protocol, which takes about 1/3 the time of the 
survival assay.  The Dar assay is more qualitative in nature, as multiple observers may differ on 
the condition of mildly-affected nematodes; however, the use of the qualitative survival covers 
discrepancies in virulence that may otherwise be debated.  
In vitro Virulence Assays 
Studying C. parapsilosis outside the host provided more depth in terms of visualizing growth 
and allowed further comparison between the isolates.  Similar studies in C. albicans have shown 
that colony morphology can be correlated to virulence (Laffey and Butler 2005).  Wrinkled 
colonies are typically more virulent, while mutants that render a smooth colony morphology are 
expected to show decreased virulence (Trofa, Gacser and Nosanchuk 2008).  This morphology is 
easily visualized by culturing the organism on yeast production media and incubating for several 
days (Laffey and Butler 2005).   
Studying the abilities of these organisms to adhere to a polystyrene surface also leads to 
inferences about the virulent capabilities of the fungi.  Adhesion is the first step in infection, as 
the pathogen must attach itself to the tissue and cells undergoing infection.  In most microbes, 
especially in Candida albicans, increased adhesion on abiotic substrates indicates a better ability 
to form biofilms and ultimately cause infection in a host (Trofa, Gacser and Nosanchuk 2008).  
This correlation also extends to experiments that test the ability of pathogens to adhere to 
epithelial cells, though such protocols are not included in this study.   
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Materials and Methods 
Two in vivo assays for virulence were performed in this virulence study of 14 Candida 
parapsilosis isolates (Table 1).  A Dar assay and survival assay were used to measure relative 
infection and mortality rates, respectively.  A study of colony morphology and a polystyrene 
adhesion assay were also used to assess the virulence characteristics of the 14 isolates.  
Deformed Anal Region (Dar) Assay 
Three adult C. elegans worms were plated on nematode growth media (NGM) plates and 
incubated for 3-5 days at 20°C until enough young eggs were present on the plate to perform and 
egg preparation.  Eggs were prepped by washing, suspending, and pelleting the C. elegans 
worms and eggs in M9 buffer and a mixture of Bleach diluted to 5.25% with DI H2O and .25 M 
NaOH.    Once the washed eggs are suspended in M9 buffer, 20-30 eggs are plated in triplicate 
on fresh NGM plates spotted with a mixture of OP50 E. coli cocultured with an isolate of C. 
parapsilosis plus streptomycin (50mg/mL) .  These plates were incubated for 5 days at 20°C 
with the number of Dar phenotype worms counted on day 3,4, and 5.  A plate with an isolate of 
C. albicans (Isolate SN250) was used as a control, as it is known to produce Dar in 100% of 
infected worms.  This procedure is modeled off recent developments of this assay (Jain, Yun, et 
al. 2009).   
Survival Assay 
An egg preparation was performed in using the same protocol described in the Dar assay.  After 
two days at 20° C, 20 worms were transferred to fresh NGM plates (triplicate sets) spotted with a 
mixture of OP50 E. coli cocultured with an isolate of C. parapsilosis plus streptomycin 
(50mg/mL) that had incubated for 24 hours after spotting at 20° C (Chiasson, et al. 2010).  The 
surviving worms were counted and transferred to fresh spotted and incubated plates every 24 
hours until no worms remained.  Worms that died as a result of crawling off the edges of the 
plates were censored in the post experimental analysis (Chiasson, et al. 2010).    
Colony Morphology 
Cultures of each isolate were grown overnight in 1X YPD broth and standardized to an equal 
concentration using a spectrophotometer.  Isolates were spotted on freshly-poured YPD media 
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plates left to incubated at 30°C overnight before being parafilmed and sitting at 4°C for at least 
14 days before morphology images were taken at 7.5X magnification.   
Adhesion to Abiotic Surfaces 
Cultures of C. parapsilosis were grown in SC media + 0.15% glucose + His + Leu + Trp + 
Uracil for 24 hours and plated in 96 well polystyrene plates (12 samples per isolate).  The plates 
were incubated at 37° C for 4 hours before aspirating and dyed with crystal violet for 45 minutes, 
rinsed with DiH2O and developed in 75% methanol for 30 minutes before reading at 590nm.  
The resulting OD readings varied significantly between isolates but there was strong consistency 
between trials; hence the use of a relative OD chart to view the data (Chiasson, et al. 2010).   
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Results  
Both in vivo and in vitro techniques were used to characterize the relative virulence of 14 isolates 
of Candida parapsilosis (see Table 1 for full listing of isolate names).  Candida albicans strains 
were used as experimental controls rather than benchmarks for virulence.   
In vivo Characterization 
The Deformed Anal Region (Dar) assay was used to show the relative severity of particular 
Candida parapsilosis isolates by infecting Caenorhabditis elegans with the fungi and observing 
the nematodes for a 5-day period.  The final day of observation frequently showed the highest 
levels of Dar phenotype, and the average rates of expression are illustrated in Figure 2.   
 
Figure 2: Dar Phenotypes on Day 5.  Isoslate CDC 317 shows significantly higher average amounts of the infected 
phenotype, while most other isolates show no infection.  The SN250 C. albicans isolate was used as a positive control.   
These average Dar percentages are taken from triplicate sets of plates, and show that CDC317 is 
producing high amounts of the Dar phenotype relative to the other isolates, which were mostly 
unable to produce the infected phenotype.  The J950218 isolate also stands out with relatively 
high levels of Dar in comparison with the other isolates and the SN250 C. albicans control, 
which is known to be highly virulent.  The isolates showing Dar phenotype were subjected to a 
survival assay that studied mortality rates of C. elegans with C. parapsilosis present.   
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Figure 3: The survival assay did not provide statistically conclusive results according to an analysis of variance and the 
short lifespan of the SN250 control plates in comparison with past studies.  The figure does, however, raise questions to be 
answered in further studies.   
While Figure 3 appears to show that isolate CDC 317 causes the fewest mortalities, an analysis 
of variance (α-level = 0.05) performed with the data indicated that the results are statistically 
inconclusive.  The results of the experiment also show that the SN250 control strain of Candida 
albicans was less able to cause mortality than isolate J950218, even though the former is known 
to be highly virulent.  Fitting liner trend lines indicated correlation coefficients (R
2
 values) of 
less than 0.73 for each isolate; however, fitting logarithmic trendlines in Excel produced R
2
 
values between 0.87 (J950218) and 0.92 (CDC 317).   
In vitro Characterization  
In addition to studying the effects of Candida parapsilosis in a live host- Caenorhabditis 
elegans, several phenotypic assays were used to investigate the 14 isolates’ behavior in vitro.  
The various Candida parapsilosis clinical isolates were incubated (Figure 4) on spider media to 
simulate a carbon starvation conditions.  
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Figure 4: Colony morphology images of all 14 isolates of Candida parapsilosis.  The isolates are separated into groups of 
totally smooth morphology (left column), uneven and non-wrinkling in the center 2 columns, and wrinkled morphology 
(right column).    
The isolates of C. parapsilosis showed a wide range of morphology structure, ranging from 
totally smooth patches with minimal or no irregular indentation on the outer edge of the colonies 
(Figure 4, left column) to very wrinkled colonies (Figure 4, right column).  While this species 
does not truly filament, the strong wrinkling morphology allows for simple qualitative grouping 
of the isolates (Laffey and Butler 2005).   The isolates shown in the two center columns of 
Figure 4 show a less-smooth morphology with irregular edges but no wrinkling structure.  The 
morphology of each isolate alone indicates little about virulence, but comparison with adhesion 
later reveled significant correlations with virulence.      
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Figure 5: Relative adhesion of all 14 isolates of Candida parapsilosis on polystyrene plates.  The results are shown in 
percentages relative to the highest average adhesion value, which was found in isolate 103.  
Pathogens must prove able to adhere to both biotic and abiotic surfaces in order to cause 
infection.  A polystyrene adhesion assay (Figure 5) was used to conveniently determine the 
relative ability of the 14 isolates to adhere to a solid surface.  The values in Figure 5 show that 
that there was a wide range of adhesion abilities observed among the isolates.  Few conclusions 
could arise from these data alone; however, correlations between adhesion, colony morphology, 
and infection rates became apparent after review.     
Discussion 
The overall goal of this project was to characterize relative virulence in 14 clinical isolates of the 
pathogenic fungi Candida parapsilosis.  The assays used to assess the pathogens included both 
in vivo types (the Dar and survival assays) and in vitro (acrylic adhesion and colony 
morphology) studies.  By comparing the data from these assays we were able to create a graphic 
representation (Figure 6) that allows easier visualization of the combined results and shows a 
correlation between low levels of adhesion, smooth colony morphology, and increased amounts 
of infection.   
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Figure 6: Comparison of Relative Adhesion with Colony Morphology and Dar Phenotype shows multiple correlations 
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Figure 6 illustrates that there is a positive correlation between smooth colony morphology and 
decreased adhesion to polystyrene surfaces.  Furthermore these in vitro infection phenotypes 
show a negative correlation with the Dar phenotype, a marker for infection in a live host.  The 
green bars indicate smooth colony morphology, showing uniform fields that are glossy, even, 
and have edges that do not wrinkle.  Notice that the green bars show a strong presence towards 
the lower end of relative adhesion values.  The wrinkled isolates, shown in red in Figure 6, also 
showed very high levels of adhesion (the lowest at 77%) and showed no Dar phenotype.  The 
blue bars represent colonies with intermediate morphology phenotypes (see Figure 4).  Note that 
this figure does not include the results obtained through the survival assay, which was 
statistically inconclusive and requires a more in-depth repeating to produce feasible results.   
Isolate CDC 317 consistently showed a completely smooth morphology with no visible 
wrinkling.  This isolate also produced an average Dar phenotype of 83% in C. elegans, indicating 
infection over than 275% more often than the next most effective isolate (J950218).  What is 
most striking about this finding is not the abnormally high infection rate that is indicate by the 
Dar assay; CDC 317 was once responsible for one of the largest Candida parapsilosis outbreaks 
in the United States over a decade ago (Kuhn, et al. 2004).  The striking discovery is the 
correlation of lower levels of adhesion with higher levels of infection in C. elegans as shown in 
Figure 6.  This begs the question of why an organism that is less able to adhere to surfaces is 
more able to cause infected phenotypes in our model?   
The answer to this question is not completely clear.  One possible explanation for the low 
adhesion/high virulence correlation may rest in the inherent morphology of C. parapsilosis, 
which is incapable of forming “true filaments” (Laffey and Butler 2005).  The less adhesive 
isolates of C. parapsilosis may simply be less able to hold onto the agarose plate surface, 
allowing the nematodes to ingest more of the low adhesion isolates than the wrinkled 
phenotypes, causing a stronger infection response in the hosts.  The translation of this virulence 
into a mammalian cells would be less direct if this were the case, but past studies have shown 
inconclusive results regarding the abilities of different strains of C. parapsilosis to adhere to 
epithelial cells (Trofa, Gacser and Nosanchuk 2008).  A beneficial future study would be to 
group cellular adhesion data by morphology as is shown in Figure 6 and to check for the same 
correlation between decreased adhesion values and increased infection rates.   
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As mentioned previously, the survival data did not show any statistically significant difference 
between the isolates in terms of mortality rates.  Repeating this experiments in greater depth, 
repeating the trials with more individuals per trial with all 14 isolates would ideally provide 
results that correlate higher infection rates with lower rates of survival.  If this were the case, it 
would provide more evidence to confirm the low adhesion/high infection rate observation, which 
would be a trait that Candida parapsilosis shares with few other pathogenic fungi.  Conversely, 
if survival assays showed strong evidence that increased mortality rates correlated directly with 
higher relative adhesion levels, we could infer that infection rates in the Dar assay were higher 
for isolates with lower adhesion levels because the fungi was less simply able to hold onto plates 
and entered the hosts in higher volumes.     
The implications of a survival assay with statistically significant differences in mortality rates is 
a critical next step in the study of Candida parapsilosis virulence.  Additionally, resourcing the 
isolates used in future experiments may be beneficial, as the generally low infection rates in the 
Dar assay may suggest a decrease in virulence as a result of long-term cryogenic storage.   
The ultimate result of this experimentation is the formation of a new hypothesis based on the 
observation that relatively low adhesion values appear to correlate with increased infection rates.  
Future studies that assess the survival rates of all 14 isolates can help determine if this increased 
infection leads to decreased levels of survival and can aid in confirming this new hypothesis and 
will be a critical step in continuing this research.  A wide array of other assays will also help 
further assess the virulence of these 14 isolates, including superoxide resistance tests and 
macrophage phagocytosis assays, both of which will aid in assessing the resilience of Candida 
parapsilosis.   
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